3 ms·
Afaik, the shortage in US is mainly of raw materials and commodity items like pipettes. How did Seegene ramp up its raw material pipeline so quickly. Really fa
by dominotw 7y ago
Afaik, the shortage in US is mainly of raw materials and commodity items like pipettes. How did Seegene ramp up its raw material pipeline so quickly. Really fascinating success.
- WillPostForFood 7y agoKorea has a broad swath of medical manufacturing capacity. A large part of the supply chain is already there, so it is easier for them to ramp up. You can double or triple output just by putting more shifts into the factories. Then you start retooling, repurposing to really ramp up.
- hilbertseries 7y agoThe US could have ramped up production, but politics and regulation prevented it. The CDC and FDA prevented any private companies from producing their own tests and in the meantime the CDC made their own small batch of tests that weren’t even accurate. If the president had taken the outbreak seriously we could have begun test production immediately, which is what South Korea did the moment they heard about the outbreak. This is largely due to systems put in place during and after the SARS and MERS outbreaks.